サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1489901

医療用バイオミメティクスの世界市場規模調査、疾患タイプ別、用途別、地域別予測：2022～2032年

Global Medical Biomimetics Market Size study, by Disease Type (Ophthalmology, Cardiovascular, Orthopedic, Dental, Others) by Application (Wound Healing, Tissue Engineering, Drug Delivery, Others) and Regional Forecasts 2022-2032
出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 200 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=150.85円
医療用バイオミメティクスの世界市場規模調査、疾患タイプ別、用途別、地域別予測：2022～2032年
出版日: 2024年05月28日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文 200 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の医療用バイオミメティクス市場は、2023年に約332億1,000万米ドルとなり、予測期間の2024年から2032年には6.70％以上の健全な成長率で成長すると予測されています。

医療用バイオミメティクスは、生物学、工学、材料科学を組み合わせて、医療問題に対する新しいアプローチを開発するものです。研究者は生物学的プロセス、構造、システムを模倣し、自然の効率性と適応性を模倣した医療技術を創造します。医療用バイオミメティクスは、人工装具、組織工学、ドラッグデリバリー、手術器具、イメージング、そしてそれ以外の分野にも応用されています。この学際的アプローチは、より安全で効果的かつ持続可能な治療や介入を提供することで、ヘルスケアに革命をもたらすことを約束します。さらに、AIは生体模倣医療技術の設計・開発プロセスへの統合が進んでいます。機械学習アルゴリズムは、複雑な生物学的システムの分析、生体模倣構造のモデル化、材料特性の最適化、新規生体模倣ソリューションの発見の加速に活用されています。

慢性疾患の増加は、医療用バイオミメティクス市場の成長を支える重要な役割を果たしています。心血管疾患、整形外科疾患、糖尿病、神経疾患などの慢性疾患は、治療と管理の面で複雑な課題を提示しています。バイオミメティック材料やデバイスは、自然の生物学的構造やプロセスを模倣できる革新的なソリューションを提供し、これらの疾患に対してより効果的な治療を提供します。その他の市場開拓要因としては、研究開発活動の活発化、ナノテクノロジーの進展、低侵襲治療に対する需要の高まり、研究開発投資の増加などが挙げられます。しかし、規制の枠組みが厳しく、開発コストが高いことが、予測期間の2024年から2032年の市場成長の妨げになると予想されます。

医療用バイオミメティクスの世界市場調査において考慮した主要地域は、アジア太平洋、北米、欧州、ラテンアメリカ、世界のその他の地域です。2023年、北米は最大の地域市場でした。北米は、高齢化、慢性疾患の増加、バイオミメティック技術の進歩などの要因によって、医療用バイオミメティクス市場の主要地域になると予測されています。NIH（米国国立衛生研究所）によると、米国の50歳以上の人口は2020年の1億3,725万人から、2050年には2億2,113万人へと61.11％増加します。50歳以上の人口のうち、少なくとも1つの慢性疾患を持つ人の数は、2020年の7,152万2,000人から、2050年までには1億4,266万人へと99.5％増加すると推定されています。その結果、高齢者人口の増加と慢性疾患の有病率の上昇が市場の成長を支えるものと予想されます。

本レポートに含まれる主な市場プレイヤーは以下の通りです：

  • Keystone Dental Group
  • CorNeat Vision
  • Syntouch Inc.
  • Zimmer Biomet Holding Inc.
  • Curasan, inc.
  • Skyler Brand Ventures LLC
  • Osteopore International Pte Ltd
  • Blatchford Limited
  • AVINENT Science and Technology
  • Otsuka Medical Devices Co., Ltd.

目次

第1章 世界の医療用バイオミメティクス市場の定義と調査の前提条件

  • 調査目的
  • 市場の定義
  • 調査の前提条件
    • 包含事項・除外事項
    • 制限事項
    • 供給サイド分析
      • 入手可能性
      • インフラ
      • 規制環境
      • 市場競争
      • 経済性（消費者の視点）
    • 需要サイド分析
      • 規制の枠組み
      • 技術の進歩
      • 環境への配慮
      • 消費者の意識と受容
  • 調査手法
  • 調査対象年
  • 通貨換算レート

第2章 エグゼクティブサマリー

  • 医療用バイオミメティクスの世界市場規模・予測（2022～2032年）
  • 地域別概要
  • セグメント別概要
    • 疾患タイプ別
    • 用途別
  • 主要動向
  • 景気後退の影響
  • アナリストの結論・提言

第3章 医療用バイオミメティクスの世界市場力学

  • 市場促進要因
  • 市場の課題
  • 市場機会

第4章 医療用バイオミメティクスの世界市場産業分析

  • ポーターのファイブフォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
    • ポーターのファイブフォースモデルへの未来的アプローチ
    • ポーターのファイブフォースの影響分析
  • PESTEL分析
    • 政治
    • 経済
    • 社会
    • 技術
    • 環境
    • 法律
  • 主要な投資機会
  • 主要な成功戦略
  • 破壊的動向
  • 業界専門家の視点
  • アナリストの結論・提言

第5章 医療用バイオミメティクスの世界市場規模・予測：疾患タイプ別、2022～2032年

  • 眼科
  • 循環器
  • 整形外科
  • 歯科
  • その他

第6章 医療用バイオミメティクスの世界市場規模・予測：用途別、2022～2032年

  • 創傷治癒
  • 組織工学
  • ドラッグデリバリー
  • その他

第7章 医療用バイオミメティクスの世界市場規模・予測：地域別、2022～2032年

  • 北米の医療用バイオミメティクス市場
    • 米国
      • 疾患タイプの内訳規模・予測、2022～2032年
      • 用途の内訳規模・予測、2022～2032年
    • カナダの医療用バイオミメティクス市場
  • 欧州の医療用バイオミメティクス市場
    • 英国の医療用バイオミメティクス市場
    • ドイツの医療用バイオミメティクス市場
    • フランスの医療用バイオミメティクス市場
    • スペインの医療用バイオミメティクス市場
    • イタリアの医療用バイオミメティクス市場
    • その他欧州の医療用バイオミメティクス市場
  • アジア太平洋の医療用バイオミメティクス市場
    • 中国の医療用バイオミメティクス市場
    • インドの医療用バイオミメティクス市場
    • 日本の医療用バイオミメティクス市場
    • オーストラリアの医療用バイオミメティクス市場
    • 韓国の医療用バイオミメティクス市場
    • その他アジア太平洋の医療用バイオミメティクス市場
  • ラテンアメリカの医療用バイオミメティクス市場
    • ブラジルの医療用バイオミメティクス市場
    • メキシコの医療用バイオミメティクス市場
    • その他ラテンアメリカの医療用バイオミメティクス市場
  • 中東・アフリカの医療用バイオミメティクス市場
    • サウジアラビアの医療用バイオミメティクス市場
    • 南アフリカの医療用バイオミメティクス市場
    • その他中東・アフリカの医療用バイオミメティクス市場

第8章 競合情報

  • 主要企業のSWOT分析
  • 主要市場戦略
  • 企業プロファイル
    • Keystone Dental Group
      • 主要情報
      • 概要
      • 財務（データの入手可能性によります）
      • 製品概要
      • 市場戦略
    • CorNeat Vision
    • Syntouch Inc.
    • Zimmer Biomet Holding Inc.
    • Curasan, inc.
    • Skyler Brand Ventures LLC
    • Osteopore International Pte Ltd
    • Blatchford Limited
    • AVINENT Science and Technology
    • Otsuka Medical Devices Co., Ltd.

第9章 調査プロセス

  • 調査プロセス
    • データマイニング
    • 分析
    • 市場推定
    • 検証
    • 出版
  • 調査属性
図表

LIST OF TABLES

  • TABLE 1. Global Medical Biomimetics market, report scope
  • TABLE 2. Global Medical Biomimetics market estimates & forecasts by Region 2022-2032 (USD Billion)
  • TABLE 3. Global Medical Biomimetics market estimates & forecasts by Disease Type 2022-2032 (USD Billion)
  • TABLE 4. Global Medical Biomimetics market estimates & forecasts by Application 2022-2032 (USD Billion)
  • TABLE 5. Global Medical Biomimetics market by segment, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 6. Global Medical Biomimetics market by region, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 7. Global Medical Biomimetics market by segment, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 8. Global Medical Biomimetics market by region, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 9. Global Medical Biomimetics market by segment, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 10. Global Medical Biomimetics market by region, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 11. Global Medical Biomimetics market by segment, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 12. Global Medical Biomimetics market by region, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 13. Global Medical Biomimetics market by segment, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 14. Global Medical Biomimetics market by region, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 15. U.S. Medical Biomimetics market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 16. U.S. Medical Biomimetics market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 17. U.S. Medical Biomimetics market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 18. Canada Medical Biomimetics market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 19. Canada Medical Biomimetics market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 20. Canada Medical Biomimetics market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 21. UK Medical Biomimetics market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 22. UK Medical Biomimetics market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 23. UK Medical Biomimetics market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 24. Germany Medical Biomimetics market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 25. Germany Medical Biomimetics market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 26. Germany Medical Biomimetics market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 27. France Medical Biomimetics market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 28. France Medical Biomimetics market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 29. France Medical Biomimetics market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 30. Italy Medical Biomimetics market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 31. Italy Medical Biomimetics market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 32. Italy Medical Biomimetics market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 33. Spain Medical Biomimetics market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 34. Spain Medical Biomimetics market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 35. Spain Medical Biomimetics market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 36. RoE Medical Biomimetics market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 37. RoE Medical Biomimetics market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 38. RoE Medical Biomimetics market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 39. China Medical Biomimetics market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 40. China Medical Biomimetics market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 41. China Medical Biomimetics market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 42. India Medical Biomimetics market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 43. India Medical Biomimetics market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 44. India Medical Biomimetics market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 45. Japan Medical Biomimetics market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 46. Japan Medical Biomimetics market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 47. Japan Medical Biomimetics market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 48. Australia Medical Biomimetics market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 49. Australia Medical Biomimetics market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 50. Australia Medical Biomimetics market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 51. South Korea Medical Biomimetics market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 52. South Korea Medical Biomimetics market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 53. South Korea Medical Biomimetics market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 54.
  • TABLE 55. RoAPAC Medical Biomimetics market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 56. RoAPAC Medical Biomimetics market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 57. RoAPAC Medical Biomimetics market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 58. Brazil Medical Biomimetics market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 59. Brazil Medical Biomimetics market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 60. Brazil Medical Biomimetics market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 61. Mexico Medical Biomimetics market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 62. Mexico Medical Biomimetics market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 63. Mexico Medical Biomimetics market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 64. RoLA Medical Biomimetics market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 65. RoLA Medical Biomimetics market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 66. RoLA Medical Biomimetics market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 67. Saudi Arabia Medical Biomimetics market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 68. Saudi Arabia Medical Biomimetics market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 69. Saudi Arabia Medical Biomimetics market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 70. South Africa Medical Biomimetics market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 71.
  • TABLE 72. South Africa Medical Biomimetics market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 73. South Africa Medical Biomimetics market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 74. RoMEA Medical Biomimetics market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 75. RoMEA Medical Biomimetics market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 76. RoMEA Medical Biomimetics market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 77. List of secondary sources, used in the study of Global Medical Biomimetics Market.
  • TABLE 78. List of primary sources, used in the study of Global Medical Biomimetics Market.
  • TABLE 79. Years considered for the study.
  • TABLE 80. Exchange rates considered.

LIST OF FIGURES

  • FIG 1. Global Medical Biomimetics market, research methodology
  • FIG 2. Global Medical Biomimetics market, market estimation techniques
  • FIG 3. Global market size estimates & forecast methods.
  • FIG 4. Global Medical Biomimetics market, key trends 2023
  • FIG 5. Global Medical Biomimetics market, growth prospects 2022-2032
  • FIG 6. Global Medical Biomimetics market, porters 5 force model
  • FIG 7. Global Medical Biomimetics market, pestel analysis
  • FIG 8. Global Medical Biomimetics market, value chain analysis
  • FIG 9. Global Medical Biomimetics market by segment, 2022 & 2032 (USD Billion)
  • FIG 10. Global Medical Biomimetics market by segment, 2022 & 2032 (USD Billion)
  • FIG 11. Global Medical Biomimetics market by segment, 2022 & 2032 (USD Billion)
  • FIG 12. Global Medical Biomimetics market by segment, 2022 & 2032 (USD Billion)
  • FIG 13. Global Medical Biomimetics market by segment, 2022 & 2032 (USD Billion)
  • FIG 14. Global Medical Biomimetics market, regional snapshot 2022 & 2032
  • FIG 15. North America Medical Biomimetics market 2022 & 2032 (USD Billion)
  • FIG 16. Europe Medical Biomimetics market 2022 & 2032 (USD Billion)
  • FIG 17. Asia pacific Medical Biomimetics market 2022 & 2032 (USD Billion)
  • FIG 18. Latin America Medical Biomimetics market 2022 & 2032 (USD Billion)
  • FIG 19. Middle East & Africa Medical Biomimetics market 2022 & 2032 (USD Billion)
  • FIG 20. Global Medical Biomimetics market, company market share analysis (2023)
目次

Global Medical Biomimetics Market is valued approximately USD 33.21 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 6.70% over the forecast period 2024-2032. Medical biomimetics combines biology, engineering, and materials science to develop novel approaches to medical problems. Researchers emulate biological processes, structures, and systems to create medical technologies that mimic nature's efficiency and adaptability. Medical biomimetics finds applications in prosthetics, tissue engineering, drug delivery, surgical tools, imaging, and beyond. This interdisciplinary approach promises to revolutionize healthcare by providing safer, more effective, and sustainable treatments and interventions. Moreover, AI is increasingly integrated into the design and development processes of biomimetic medical technologies. Machine learning algorithms are utilized to analyze complex biological systems, model biomimetic structures, optimize material properties, and accelerate the discovery of novel biomimetic solutions.

The increasing incidence of chronic diseases plays a significant role in supporting the growth of the Medical Biomimetics Market. Chronic diseases such as cardiovascular diseases, orthopedic disorders, diabetes, and neurological disorders present complex challenges in terms of treatment and management. Biomimetic materials and devices offer innovative solutions that can mimic natural biological structures and processes, providing more effective treatments for these conditions. Additionally, other factors support the market growth are increasing research and development activities, growing advancement in nanotechnology, rising demand for minimally invasive procedures, and increasing research and development investments. However, stringent regulatory framework, and high development costs are expected to hinder the market growth during the forecast period 2024-2032.

The key regions considered for the global Medical Biomimetics market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. In 2023, North America was the largest regional market. North America is projected to be the leading region in the Medical Biomimetics market, driven by factors such as an ageing population, rising prevalence of chronic illnesses, and ongoing advancements in biomimetic technology. As per NIH (National Institutes of Health), the number of people in the United States aged 50 years and older will increase by 61.11% from 137.25 million in 2020 to 221.13 million in 2050. Of the population 50 years and older, the number with at least one chronic disease is estimated to increase by 99.5% from 71.522 million in 2020 to 142.66 million by 2050. As a result, the growing old age population and rising prevalence of chronic disease is anticipated to support the market growth.

Major market player included in this report are:

  • Keystone Dental Group
  • CorNeat Vision
  • Syntouch Inc.
  • Zimmer Biomet Holding Inc.
  • Curasan, inc.
  • Skyler Brand Ventures LLC
  • Osteopore International Pte Ltd
  • Blatchford Limited
  • AVINENT Science and Technology
  • Otsuka Medical Devices Co., Ltd.

The detailed segments and sub-segment of the market are explained below:

By Disease Type

  • Ophthalmology
  • Cardiovascular
  • Orthopedic
  • Dental
  • Others

By Application

  • Wound Healing
  • Tissue Engineering
  • Drug Delivery
  • Others

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • RoMEA

Years considered for the study are as follows:

  • Historical year - 2022
  • Base year - 2023
  • Forecast period - 2024 to 2032

Key Takeaways:

  • Market Estimates & Forecast for 10 years from 2022 to 2032.
  • Annualized revenues and regional level analysis for each market segment.
  • Detailed analysis of geographical landscape with Country level analysis of major regions.
  • Competitive landscape with information on major players in the market.
  • Analysis of key business strategies and recommendations on future market approach.
  • Analysis of competitive structure of the market.
  • Demand side and supply side analysis of the market

Table of Contents

Chapter 1. Global Medical Biomimetics Market Definition and Research Assumptions

  • 1.1. Research Objective
  • 1.2. Market Definition
  • 1.3. Research Assumptions
    • 1.3.1. Inclusion & Exclusion
    • 1.3.2. Limitations
    • 1.3.3. Supply Side Analysis
      • 1.3.3.1. Availability
      • 1.3.3.2. Infrastructure
      • 1.3.3.3. Regulatory Environment
      • 1.3.3.4. Market Competition
      • 1.3.3.5. Economic Viability (Consumer's Perspective)
    • 1.3.4. Demand Side Analysis
      • 1.3.4.1. Regulatory frameworks
      • 1.3.4.2. Technological Advancements
      • 1.3.4.3. Environmental Considerations
      • 1.3.4.4. Consumer Awareness & Acceptance
  • 1.4. Estimation Methodology
  • 1.5. Years Considered for the Study
  • 1.6. Currency Conversion Rates

Chapter 2. Executive Summary

  • 2.1. Global Medical Biomimetics Market Size & Forecast (2022- 2032)
  • 2.2. Regional Summary
  • 2.3. Segmental Summary
    • 2.3.1. By Disease Type
    • 2.3.2. By Application
  • 2.4. Key Trends
  • 2.5. Recession Impact
  • 2.6. Analyst Recommendation & Conclusion

Chapter 3. Global Medical Biomimetics Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Challenges
  • 3.3. Market Opportunities

Chapter 4. Global Medical Biomimetics Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model
    • 4.1.7. Porter's 5 Force Impact Analysis
  • 4.2. PESTEL Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
    • 4.2.5. Environmental
    • 4.2.6. Legal
  • 4.3. Top investment opportunity
  • 4.4. Top winning strategies
  • 4.5. Disruptive Trends
  • 4.6. Industry Expert Perspective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Medical Biomimetics Market Size & Forecasts by Disease Type 2022-2032

  • 5.1. Ophthalmology
  • 5.2. Cardiovascular
  • 5.3. Orthopedic
  • 5.4. Dental
  • 5.5. Others

Chapter 6. Global Medical Biomimetics Market Size & Forecasts by Application 2022-2032

  • 6.1. Wound Healing
  • 6.2. Tissue Engineering
  • 6.3. Drug Delivery
  • 6.4. Others

Chapter 7. Global Medical Biomimetics Market Size & Forecasts by Region 2022-2032

  • 7.1. North America Medical Biomimetics Market
    • 7.1.1. U.S. Medical Biomimetics Market
      • 7.1.1.1. Disease Type breakdown size & forecasts, 2022-2032
      • 7.1.1.2. Application breakdown size & forecasts, 2022-2032
    • 7.1.2. Canada Medical Biomimetics Market
  • 7.2. Europe Medical Biomimetics Market
    • 7.2.1. U.K. Medical Biomimetics Market
    • 7.2.2. Germany Medical Biomimetics Market
    • 7.2.3. France Medical Biomimetics Market
    • 7.2.4. Spain Medical Biomimetics Market
    • 7.2.5. Italy Medical Biomimetics Market
    • 7.2.6. Rest of Europe Medical Biomimetics Market
  • 7.3. Asia-Pacific Medical Biomimetics Market
    • 7.3.1. China Medical Biomimetics Market
    • 7.3.2. India Medical Biomimetics Market
    • 7.3.3. Japan Medical Biomimetics Market
    • 7.3.4. Australia Medical Biomimetics Market
    • 7.3.5. South Korea Medical Biomimetics Market
    • 7.3.6. Rest of Asia Pacific Medical Biomimetics Market
  • 7.4. Latin America Medical Biomimetics Market
    • 7.4.1. Brazil Medical Biomimetics Market
    • 7.4.2. Mexico Medical Biomimetics Market
    • 7.4.3. Rest of Latin America Medical Biomimetics Market
  • 7.5. Middle East & Africa Medical Biomimetics Market
    • 7.5.1. Saudi Arabia Medical Biomimetics Market
    • 7.5.2. South Africa Medical Biomimetics Market
    • 7.5.3. Rest of Middle East & Africa Medical Biomimetics Market

Chapter 8. Competitive Intelligence

  • 8.1. Key Company SWOT Analysis
  • 8.2. Top Market Strategies
  • 8.3. Company Profiles
    • 8.3.1. Keystone Dental Group
      • 8.3.1.1. Key Information
      • 8.3.1.2. Overview
      • 8.3.1.3. Financial (Subject to Data Availability)
      • 8.3.1.4. Product Summary
      • 8.3.1.5. Market Strategies
    • 8.3.2. CorNeat Vision
    • 8.3.3. Syntouch Inc.
    • 8.3.4. Zimmer Biomet Holding Inc.
    • 8.3.5. Curasan, inc.
    • 8.3.6. Skyler Brand Ventures LLC
    • 8.3.7. Osteopore International Pte Ltd
    • 8.3.8. Blatchford Limited
    • 8.3.9. AVINENT Science and Technology
    • 8.3.10. Otsuka Medical Devices Co., Ltd.

Chapter 9. Research Process

  • 9.1. Research Process
    • 9.1.1. Data Mining
    • 9.1.2. Analysis
    • 9.1.3. Market Estimation
    • 9.1.4. Validation
    • 9.1.5. Publishing
  • 9.2. Research Attributes